BUILT TO LAST

Bristol-Myers Squibb Company

Application Filed: 2020-09-15
Trademark Application Details
Trademark Logo BUILT TO LAST

Mark For: BUILT TO LAST™ trademark registration is intended to cover the categories of pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for use in disease testing. [all]

Status

2023-06-12 UTC
DEAD APPLICATION Refused Dismissed or Invalidated
This trademark application was refused, dismissed, or invalidated by the Office and this application is no longer active.


Research OneLook Acronym Finder
Serial Number90182586
Mark Literal ElementsBUILT TO LAST
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK. SERVICE MARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2021-11-09
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 005: Adhesives
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameMarilyn F. Kelly
Attorney Docket Number00156563-US

Timeline

2020-09-15Application Filed
2020-09-18Location: NEW APPLICATION PROCESSING
2020-09-18Status: Live/Pending
2020-09-18Transaction Date
2021-09-14Published
2021-11-09Location: INTENT TO USE SECTION
2022-12-12Status: Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all docume

Trademark Parties (Applicants & Owners)

Party: Bristol-Myers Squibb Company
Address430 E. 29th Street, 14th Floor New York, NEW YORK UNITED STATES 10016
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Attorney of Record

MARILYN F. KELLY
BRISTOL-MYERS SQUIBB COMPANY
P.O. BOX 4000
TRADEMARKS DEPT., MAILSTOP D4243
PRINCETON, NJ 08648-4000

Good, Services, and Codes

(ABANDONED)
IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for use in disease testing(ABANDONED)
IC 016. US 002 005 022 023 029 037 038 050. G & S: Printed matter, namely, magazines, books, booklets, brochures, pamphlets, newsletters and catalogs in the field of pharmaceutical preparations for the treatment of cancer(ABANDONED)
IC 044. US 100 101. G & S: Medical information services, namely, providing medical information to physicians, health care professionals, and patients on the topic of cancer

International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:16
U.S. Codes:002,005,022,023,029,037,038,050
International Codes:44
U.S. Codes:100,101
Type CodeType
GS0051Pharmaceutical preparations for human use

Trademark Filing History

DescriptionDateProceeding Number
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED2022-12-12
ABANDONMENT - NO USE STATEMENT FILED2022-12-1299999
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2022-05-10
TEAS EXTENSION RECEIVED2022-05-06
SOU EXTENSION 1 GRANTED2022-05-0698765
SOU EXTENSION 1 FILED2022-05-0698765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2021-11-09
PUBLISHED FOR OPPOSITION2021-09-14
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2021-09-14
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2021-08-26
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED2021-08-056328
EXAMINERS AMENDMENT E-MAILED2021-08-056328
EXAMINERS AMENDMENT -WRITTEN2021-08-0578048
EXAMINER'S AMENDMENT ENTERED2021-08-0588888
APPROVED FOR PUB - PRINCIPAL REGISTER2021-08-05
TEAS/EMAIL CORRESPONDENCE ENTERED2021-07-3088889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2021-07-29
CORRESPONDENCE RECEIVED IN LAW OFFICE2021-07-2988889
NOTIFICATION OF NON-FINAL ACTION E-MAILED2021-02-016325
NON-FINAL ACTION WRITTEN2021-02-0178048
NON-FINAL ACTION E-MAILED2021-02-016325
ASSIGNED TO EXAMINER2021-01-2778048
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED2020-10-22
NEW APPLICATION ENTERED IN TRAM2020-09-18
NEW APPLICATION ENTERED2020-09-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed